These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30701562)

  • 61. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
    Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
    Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
    Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
    J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
    Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
    Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
    García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
    Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
    [TBL] [Abstract][Full Text] [Related]  

  • 68. B cell memory responses induced by foot-and-mouth disease virus-like particles in BALB/c mice.
    Liu JH; Zhang JJ; Han WJ; Cui C; Li MZ; Tian ZY; Bai RM; Li LM
    Vet Immunol Immunopathol; 2022 Aug; 250():110458. PubMed ID: 35841772
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G; Wang H; Wang F; Yu L
    Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunization of mice by hollow mesoporous silica nanoparticles as carriers of porcine circovirus type 2 ORF2 protein.
    Guo HC; Feng XM; Sun SQ; Wei YQ; Sun DH; Liu XT; Liu ZX; Luo JX; Yin H
    Virol J; 2012 Jun; 9():108. PubMed ID: 22691538
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
    Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
    Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
    Di Giacomo S; Brito BP; Perez AM; Bucafusco D; Pega J; Rodríguez L; Borca MV; Pérez-Filgueira M
    Transbound Emerg Dis; 2015 Jun; 62(3):280-7. PubMed ID: 23895140
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
    Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of bovine IFN-alpha on the immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus.
    Guo HC; Liu ZX; Sun SQ; Leng QW; Li D; Liu XT; Xie QG
    Acta Biochim Biophys Sin (Shanghai); 2004 Oct; 36(10):701-6. PubMed ID: 15483751
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunoprotective mechanisms in swine within the "grey zone" in antibody response after immunization with foot-and-mouth disease vaccine.
    Zhang L; Feng X; Jin Y; Ma J; Cai H; Zhang X
    Virus Res; 2016 Jul; 220():39-46. PubMed ID: 27067203
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
    Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
    Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
    Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V
    Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
    Yao Q; Qian P; Huang Q; Cao Y; Chen H
    J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.